The global Intradermal Injection market size was estimated to be US$ 3.3 billion in 2021 and is expected grow at a CAGR of 10.5% between 2023 to 2032. Intradermal injection is the process of injecting ...
The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...
The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination. In a hallmark study ...
Monkeypox continues to spread in the U.S., with more than 10,000 cases documented across the country, according to data from the Centers for Disease Control and Prevention (CDC). Still, access to the ...
People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...
Algunos resultados se han ocultado porque es posible que no sean accesibles para usted.
Mostrar resultados inaccesibles